OliX Pharmaceuticals,Inc (226950.KQ) KOE
164,000.00
-14800(-8.28%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
164,000.00
-14800(-8.28%)
Currency In KRW
| Market Cap | 2.83T |
| Enterprise Value | 2.85T |
| P/E Ratio | -203.98 |
| PEG Ratio | -3.31 |
| Price/Sales Ratio | 224.92 |
| Price/Book Ratio | 22.17 |
| Enterprise/Revenue | 226.07 |
| Enterprise/EBITDA | -120.49 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | December 31, 2025 |
| Profit Margin | -1.11 |
| Operating Margin | -2.08 |
| Return On Assets | -0.08 |
| Return On Equity | -0.19 |
| Revenue | 14.67B |
| Revenue/Share | 726.44 |
| Gross Profit | 0 |
| EBITDA | -27.52B |
| Net Income | -16.23B |
| Diluted EPS | -804 |
| Total Cash | 132.51B |
| Total Cash/Share | 6,563.32 |
| Total Debt | 23.29B |
| Total Debt/Equity | 0.16 |
| Current Ratio | 6.6 |
| Book Value Per Share | 7,433.32 |
| 52-Week Change | 293.76 |
| 52-Week High | 217,000 |
| 52-Week Low | 34,500 |
| Moving Average 50 Days | 161,372 |
| Moving Average 200 Days | 106,792.25 |
| Average Volume | 455,216 |
| Shares Outstanding | 20.11M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | December 03, 2020 |